WBR280: Difference between revisions

Jump to navigation Jump to search
Sergekorjian (talk | contribs)
No edit summary
Sergekorjian (talk | contribs)
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=Gerald Chi
|QuestionAuthor=Gerald Chi (Reviewed by Serge Korjian)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|MainCategory=Microbiology, Pharmacology
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology
|SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology
|Prompt=An 8-year-old girl with a history of thalassaemia major presents to the emergency department with low-grade fever, leg pain, and malaise for the past week. Her blood pressure is 110/60 mm Hg, heart rate is 90/min, and temperature is 37.8 ᵒC (100 ᵒF). On physical examination, her anterior left shin is red, swollen, and tender to palpation. Two sets of blood cultures are positive for gram-negative bacteria and MRI confirms a diagnosis of tibial osteomyelitis. Which of the following antimicrobial agent is the most appropriate initial therapy?
|Prompt=An 8-year-old girl with a history of thalassaemia major presents to the emergency department with low-grade fever, leg pain, and malaise for the past week. Her blood pressure is 110/60 mm Hg, heart rate is 90/min, and temperature is 37.8 ᵒC (100 ᵒF). On physical examination, her anterior left shin is red, swollen, and tender to palpation. Two sets of blood cultures are positive for gram-negative bacteria and MRI confirms a diagnosis of tibial osteomyelitis. Which of the following antimicrobial agent is the most appropriate initial therapy?
|Explanation=Patients with a history of hemoglobinopathy such as sickle cell disease and thalassemia are prone to have osteomyelitis secondary to Salmonella infection. Other risk factors include transfusions and iron chelation therapies.
|Explanation=Patients with a history of hemoglobinopathy such as sickle cell disease and thalassemia are prone to have osteomyelitis secondary to Salmonella infection. Other risk factors include transfusions and iron chelation therapies.
Line 30: Line 30:
|AnswerCExp=Intravenous nafcillin may be used as a primary regimen for S. aureus osteomyelitis
|AnswerCExp=Intravenous nafcillin may be used as a primary regimen for S. aureus osteomyelitis
|AnswerD=Intravenous vancomycin
|AnswerD=Intravenous vancomycin
|AnswerDExp=Intravenous vancomycin may be used as an alternative regimen for S. aureus osteomyelitis
|AnswerDExp=Intravenous vancomycin may be used as an alternative regimen for MRSA osteomyelitis
|AnswerE=Intravenous cefazolin
|AnswerE=Intravenous cefazolin
|AnswerEExp=Intravenous cefazolin may be used as a primary regimen for S. aureus osteomyelitis
|AnswerEExp=Intravenous cefazolin may be used as a primary regimen for S. aureus osteomyelitis
|RightAnswer=A
|RightAnswer=A
|WBRKeyword=Salmonella
|WBRKeyword=Salmonella, Osteomyelitis, Antibiotics, Thalassemia, Sickle cell disease
|Approved=Yes
|Approved=Yes
}}
}}

Revision as of 15:27, 7 August 2015

 
Author PageAuthor::Gerald Chi (Reviewed by Serge Korjian)
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Microbiology, MainCategory::Pharmacology
Sub Category SubCategory::Head and Neck, SubCategory::Hematology, SubCategory::Musculoskeletal/Rheumatology
Prompt [[Prompt::An 8-year-old girl with a history of thalassaemia major presents to the emergency department with low-grade fever, leg pain, and malaise for the past week. Her blood pressure is 110/60 mm Hg, heart rate is 90/min, and temperature is 37.8 ᵒC (100 ᵒF). On physical examination, her anterior left shin is red, swollen, and tender to palpation. Two sets of blood cultures are positive for gram-negative bacteria and MRI confirms a diagnosis of tibial osteomyelitis. Which of the following antimicrobial agent is the most appropriate initial therapy?]]
Answer A AnswerA::Intravenous ciprofloxacin
Answer A Explanation AnswerAExp::Intravenous ciprofloxacin is the drug of choice for Salmonella osteomyelitis
Answer B AnswerB::Intravenous linezolid
Answer B Explanation AnswerBExp::Intravenous linezolid may be used as an alternative regimen for MRSA osteomyelitis
Answer C AnswerC::Intravenous nafcillin
Answer C Explanation AnswerCExp::Intravenous nafcillin may be used as a primary regimen for S. aureus osteomyelitis
Answer D AnswerD::Intravenous vancomycin
Answer D Explanation AnswerDExp::Intravenous vancomycin may be used as an alternative regimen for MRSA osteomyelitis
Answer E AnswerE::Intravenous cefazolin
Answer E Explanation AnswerEExp::Intravenous cefazolin may be used as a primary regimen for S. aureus osteomyelitis
Right Answer RightAnswer::A
Explanation [[Explanation::Patients with a history of hemoglobinopathy such as sickle cell disease and thalassemia are prone to have osteomyelitis secondary to Salmonella infection. Other risk factors include transfusions and iron chelation therapies.

Educational Objective:
References: ]]

Approved Approved::Yes
Keyword WBRKeyword::Salmonella, WBRKeyword::Osteomyelitis, WBRKeyword::Antibiotics, WBRKeyword::Thalassemia, WBRKeyword::Sickle cell disease
Linked Question Linked::
Order in Linked Questions LinkedOrder::